Convergence Investment Partners’s Colgate-Palmolive CL Stock Holding History

Convergence Investment Partners’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-14,545	Closed	-$1.16M	–	251
2025 Q3	$1.16M	Buy	14,545 +1,586	+12%	+$135K	0.26%	141
2025 Q2	$1.18M	Buy	+12,959	New	+$1.18M	0.3%	125
2023 Q1	–	Sell	-3,960	Closed	-$312K	–	191
2022 Q4	$312K	Sell	3,960 -151	-4%	-$11.3K	0.18%	122
2022 Q3	$289K	Buy	+4,111	New	+$322K	0.19%	118
2019 Q4	–	Sell	-17,331	Closed	-$1.27M	–	241
2019 Q3	$1.27M	Sell	17,331 -4,803	-22%	-$348K	0.35%	99
2019 Q2	$1.59M	Buy	+22,134	New	+$1.57M	0.38%	101
2018 Q2	–	Sell	-1,697	Closed	-$122K	–	427
2018 Q1	$122K	Buy	+1,697	New	+$122K	0.02%	327

Other funds holding CL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Convergence Investment Partners's CL Position: Q4 2025 in Review

Convergence Investment Partners sold out of Colgate-Palmolive (CL) in Q4 2025, closing a stake of 14,545 shares — an estimated $1.16M sold.

Convergence Investment Partners first reported a position in CL in Q1 2018 and held it in 7 quarters. The position peaked at $1.59M in Q2 2019. 1,892 funds tracked by Wall St. Rank hold CL as of Q4 2025.

Convergence Investment Partners reported no remaining Colgate-Palmolive position as of Q4 2025 after selling out during the quarter.
Convergence Investment Partners sold 14,545 Colgate-Palmolive shares in Q4 2025, an estimated $1.16M.
Convergence Investment Partners first reported a position in Colgate-Palmolive in Q1 2018 and held it in 7 quarters.
Convergence Investment Partners's Colgate-Palmolive position peaked at $1.59M in Q2 2019.
1,892 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q4 2025.

Based on Convergence Investment Partners's 13F filing for Q4 2025, filed 5 Feb 2026.